RUPP RANDALL 4

4 · REGENERON PHARMACEUTICALS INC · Filed Jan 7, 2005

Insider Transaction Report

Form 4

Period: 2005-01-05

REGENERON PHARMACEUTICALS INCREGN

RUPP RANDALL

SVP, Manuf & Process Sciences

Transactions

Award
Non-Qualified Stock Option (right to buy)
2005-01-05+8,594→ 9,999 total
Exercise: $8.50Exp: 2011-01-05→ Common Stock (8,594 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-01-05+3,431→ 3,431 total
Exercise: $8.50Exp: 2012-12-20→ Common Stock (3,431 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2005-01-05−5,147→ 0 total
Exercise: $19.43Exp: 2012-12-20→ Common Stock (5,147 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-01-05+29,902→ 33,333 total
Exercise: $8.50Exp: 2012-12-20→ Common Stock (29,902 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2005-01-05−4,216→ 0 total
Exercise: $37.78Exp: 2010-12-21→ Common Stock (4,216 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-01-05+1,405→ 1,405 total
Exercise: $8.50Exp: 2011-01-05→ Common Stock (1,405 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-01-05+15,000→ 15,000 total
Exercise: $8.50Exp: 2011-12-18→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-01-05−44,853→ 0 total
Exercise: $19.43Exp: 2012-12-20→ Common Stock (44,853 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-01-05−25,784→ 0 total
Exercise: $37.78Exp: 2010-12-21→ Common Stock (25,784 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-01-05−30,000→ 0 total
Exercise: $28.01Exp: 2011-12-18→ Common Stock (30,000 underlying)

Footnotes (4)

[F1]The stock option award (combined incentive stock option and non-qualified stock option) was originally granted on December 20, 2002 and vests in four equal annual installments, commencing one year after the date of grant.
[F2]The stock option award (combined incentive stock option and non-qualified stock option) was originally granted on December 21, 2000 and vests in five equal annual installments, commencing one year after the date of grant.
[F3]The option becomes fully exercisable with respect to all shares underlying the option if the Company's products achieve aggregate, worldwide gross sales of at least US$100 million during any consecutive twelve-month period based on sales directly by the Company and/or its licensees, affiliates, and distributors (the "Milestone Date") unless the Milestone Date occurs before the third anniversary of the grant date, in which case all of the shares underlying the option become fully vested on the third anniversary of the grant date.
[F4]The stock option award (combined incentive stock option and non-qualified stock option) was originally granted on December 18, 2001 and vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT